1. Home
  2. GLP vs ARQT Comparison

GLP vs ARQT Comparison

Compare GLP & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLP
  • ARQT
  • Stock Information
  • Founded
  • GLP 2005
  • ARQT 2016
  • Country
  • GLP United States
  • ARQT United States
  • Employees
  • GLP N/A
  • ARQT N/A
  • Industry
  • GLP Oil Refining/Marketing
  • ARQT Biotechnology: Pharmaceutical Preparations
  • Sector
  • GLP Energy
  • ARQT Health Care
  • Exchange
  • GLP Nasdaq
  • ARQT Nasdaq
  • Market Cap
  • GLP 1.8B
  • ARQT 2.1B
  • IPO Year
  • GLP 2005
  • ARQT 2020
  • Fundamental
  • Price
  • GLP $51.10
  • ARQT $17.40
  • Analyst Decision
  • GLP Hold
  • ARQT Strong Buy
  • Analyst Count
  • GLP 1
  • ARQT 7
  • Target Price
  • GLP $56.00
  • ARQT $19.00
  • AVG Volume (30 Days)
  • GLP 80.3K
  • ARQT 1.5M
  • Earning Date
  • GLP 11-07-2025
  • ARQT 11-05-2025
  • Dividend Yield
  • GLP 5.88%
  • ARQT N/A
  • EPS Growth
  • GLP N/A
  • ARQT N/A
  • EPS
  • GLP 2.60
  • ARQT N/A
  • Revenue
  • GLP $17,827,598,000.00
  • ARQT $263,464,999.00
  • Revenue This Year
  • GLP $37.98
  • ARQT $72.46
  • Revenue Next Year
  • GLP $28.27
  • ARQT $31.69
  • P/E Ratio
  • GLP $19.62
  • ARQT N/A
  • Revenue Growth
  • GLP 3.74
  • ARQT 99.50
  • 52 Week Low
  • GLP $42.88
  • ARQT $8.03
  • 52 Week High
  • GLP $60.00
  • ARQT $18.15
  • Technical
  • Relative Strength Index (RSI)
  • GLP 46.48
  • ARQT 61.47
  • Support Level
  • GLP $50.88
  • ARQT $16.62
  • Resistance Level
  • GLP $52.68
  • ARQT $17.80
  • Average True Range (ATR)
  • GLP 1.22
  • ARQT 0.67
  • MACD
  • GLP -0.14
  • ARQT 0.01
  • Stochastic Oscillator
  • GLP 26.37
  • ARQT 75.32

About GLP Global Partners LP Common Units representing Limited Partner Interests

Global Partners LP is a limited partnership that acts as a midstream logistics and marketing company. It is mainly engaged in purchasing, selling, storing and logistics of transporting petroleum and related products. The company owns and operates and control terminal networks of refined petroleum products and renewable fuels in Massachusetts, Maine, Connecticut, Vermont, and other places. It distributes gasoline and gasoline blendstocks, distillates, residual oil, renewable fuels, crude oil, natural gas and propane to wholesalers, retailers and commercial customers. The company operates through three segments i.e. Wholesale, Gasoline Distribution and Station Operations and Commercial. It generates maximum revenue from the Wholesale segment.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

Share on Social Networks: